Tag Archives: medtech
Sofinnova Partners Closed Its Crossover II Fund at €725 Million, Above Target, to Back Late-Stage European Life Sciences Companies:
Sofinnova Partners, the Paris-, London- and Milan-based life sciences venture firm, announced on November 16 the final close of Sofinnova Crossover II at €725 million ($815 million… Continue reading